ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC

March 11, 1977

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com.

August 8, 2003